This Biopharmaceutical Stock Could Triple From Current Levels
The biopharmaceutical stock discussed in today’s article could triple from current levels if the positive thesis of one analyst covering the stock plays out –…
The biopharmaceutical stock discussed in today’s article could triple from current levels if the positive thesis of one analyst covering the stock plays out –…
Today’s article highlights 10 stocks that traders may want to add to their watchlists this week, as each appears poised for a possible breakout in…
New China stocks listed on the Nasdaq/NYSE that are involved in cloud computing, mobile apps and Internet advertising, and a life sciences company using tech…
“These are four quality stocks to buy that have value characteristics but also appear to have the hidden potential to have momentum stock upside,” says…
Tech companies involved in the software, cloud computing, mobile app and telecom sectors are among the new tech stocks to watch highlighted in today’s article,…
Like many healthcare stocks, the two discussed in today’s article hit price highs over the past year. Unlike many healthcare stocks, however, they didn’t necessarily…
Amid growing acceptance of the use of psychedelic drugs for treating mental disorders, the clinical-stage biotech company featured in today’s article, which has a pipeline…
With nine FDA-approved products and more than 30 product candidates in clinical development – including a potential COVID-19 therapeutic – the biotechnology company featured in…
When it comes to the three biotech stocks discussed in today’s article, all of which are down 45% or more from their 52-week highs, should…
There’s a severe shortage of semiconductors – the worst shortage in 30 years according to one analysis – and it’s being felt across many industries,…